Vident Partners provides vetted urogynecology expert witnesses for cases involving surgical mesh complications, pelvic organ prolapse repair, stress urinary incontinence surgery, bladder and bowel injury, informed consent, and mesh removal nationwide. Request a referral today.
Find a Urogynecology Expert →Overview
A urogynecology expert answers whether a pelvic floor operation was the right one for this patient, whether it was done properly, and whether a complication was recognized and managed. Mesh dominates the field's litigation, but the same questions apply to any repair. The expert separates a known risk from a departure in care. On the device side, the expert separates a problem with the product from a problem with how it was used. This page covers female pelvic floor surgery. Urologic care in general and general gynecology have their own pages.
The first mistake to avoid is treating all mesh as one thing. The FDA says there are three main procedures performed with surgical mesh for pelvic floor disorders: transvaginal mesh to treat pelvic organ prolapse, transabdominal mesh to treat prolapse, and a mesh sling to treat stress urinary incontinence 1. The agency says each has unique risks and benefits and warns against confusing them 1. An opinion must name the procedure, the product, and the date.
The regulatory history for transvaginal prolapse mesh is short and pointed:
Different rules apply to slings. FDA's page on stress urinary incontinence describes studies, ordered under its postmarket authority, comparing mini-slings with traditional mid-urethral slings, and reports that mini-slings showed comparable effectiveness and similar types and rates of adverse events through 36 months 3. The adverse events assessed included mesh erosion, organ perforation, mesh exposure, severe pain and re-surgery 3. So a sling claim stands on a different record than a prolapse mesh claim.
The FDA says people who received transvaginal prolapse mesh should continue routine follow-up and that there is no need to take additional action if they are satisfied and have no symptoms 1. They should tell their provider of complications or symptoms, including persistent vaginal bleeding 1. That framing matters to causation and to a removal decision. Removal is itself major surgery, and it may not relieve all symptoms. An expert compares what the patient reported, what examination and imaging found, and what the operation achieved.
For surgical conduct, the expert reviews whether conservative options were considered, whether the operation fit the anatomy and symptoms, and how the patient was counseled. The evaluation may include examination findings and any urodynamic testing. The operative note is read for port or trocar placement, bladder inspection, and any concurrent procedures. Bladder, ureter and bowel injuries are known risks, so the question is often whether the injury was recognized at surgery or soon after. A patient who has urine leakage, fever or severe pain after surgery should prompt a timely search for the cause.
Consent is often central, because what a patient was told depends on the date. Guidance and warnings changed over the years, so the expert should anchor the opinion to what was known at the time of surgery. The treating surgeon's own training on the device can also be relevant.
A product claim brings federal questions. Riegel v. Medtronic held that the Medical Device Amendments bar common-law claims challenging the safety or effectiveness of a device marketed in a form that received premarket approval 4. Many older mesh products reached the market by a different route, so counsel should identify how the particular device was cleared, since that may decide whether the defense applies.
Look for a physician with fellowship training in female pelvic medicine and reconstructive surgery who performs the operation at issue and manages its complications. Experience with mesh removal is especially useful. A urologist may fit depending on the procedure. The NIDDK says treatment depends on the type of urinary incontinence a person has, so the diagnosis itself can be a point of dispute 5. A biomedical engineer or materials scientist addresses the mesh itself. A pathologist addresses explanted tissue, and a pain specialist or life care planner addresses ongoing need.
On April 16, 2019, the FDA ordered all manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling and distributing their products immediately.
Case Types
Transvaginal mesh erosion, exposure, and chronic pain
Mid-urethral sling complications
Mesh removal surgery and its outcomes
Bladder, ureter, and bowel injury during pelvic surgery
Failure to recognize a post-operative complication
Informed consent for mesh or pelvic floor surgery
Prolapse repair failure and recurrence
Product liability claims against mesh manufacturers
Qualifications
Related Specialties
FAQ
Look for fellowship training in female pelvic medicine and reconstructive surgery, active practice in the operation at issue, and direct experience with complications and mesh removal. A urologist may fit depending on the procedure. The expert should know the FDA record as of the date of surgery.
It depends on the use. The FDA says there are currently no FDA-approved surgical mesh products for transvaginal repair of prolapse marketed in the United States. Transabdominal prolapse mesh and slings for stress urinary incontinence are different procedures with different records.
On April 16, 2019, the FDA ordered manufacturers to stop selling and distributing these products after reviewing their premarket approval applications. It determined the manufacturers did not demonstrate reasonable assurance of safety and effectiveness.
This is a medical question for a treating physician. The FDA says people who received transvaginal prolapse mesh should continue routine follow-up, and there is no need to take additional action if they are satisfied and have no complications or symptoms. Litigation may ask what symptoms were reported and what was done.
That depends on how the device reached the market. Riegel v. Medtronic held that common-law claims challenging the safety or effectiveness of a premarket approved device are barred. Many older mesh products reached the market by another route, so counsel should identify the specific clearance history.
In general, urogynecology expert fees are determined by the expert themselves, based on a variety of criteria. Among those criteria are clinical experience, board certifications, forensic experience, academic appointments, and publications. Vident does have some influence over expert fees by comparing experts within a specialty, but ultimately it is a personal decision by the expert.
Related Insights
Most of us have signed a hospital consent form without reading every word. A recent Vermont Supreme Court decision, Ford v. Polomsky, shows what can happen when a patient later says, "I never agreed t...
Practice Area IntelligenceOver the past several years I have reviewed medical charts for both insurance companies and pain clinics to determine if what has been recorded makes good medical sense and shows an appropriate level...
Research BriefingFentanyl, a synthetic opioid, was first developed by Dr. Paul Janssen in the 1960s. From its inception, it was designed to be fast-acting, highly potent, and more readily synthesized than naturally oc...
Sources
Vident Partners connects attorneys with qualified urogynecology expert witnesses. Complimentary consultation, 24-hour turnaround, no obligation.
Request an Expert →